Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High temperature requirement A1 and macrophage migration inhibitory factor in the cerebrospinal fluid; a potential marker of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
Hjæresen S, Benedikz E, Sejbaek T, Axelsson M, Novakova L, Zhang M, Lycke J, Illes Z, Fex-Svenningsen Å. Hjæresen S, et al. Among authors: lycke j. J Neurol Sci. 2024 Feb 15;457:122888. doi: 10.1016/j.jns.2024.122888. Epub 2024 Jan 14. J Neurol Sci. 2024. PMID: 38278096 Free article.
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Mattsson N, Axelsson M, Haghighi S, Malmeström C, Wu G, Anckarsäter R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, Johnsen L, Fladby T, Tarkowski A, Trysberg E, Wallin A, Anckarsäter H, Lycke J, Andersen O, Simon AJ, Blennow K, Zetterberg H. Mattsson N, et al. Among authors: lycke j. Mult Scler. 2009 Apr;15(4):448-54. doi: 10.1177/1352458508100031. Epub 2009 Jan 19. Mult Scler. 2009. PMID: 19153172
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J. Gunnarsson M, et al. Among authors: lycke j. Ann Neurol. 2011 Jan;69(1):83-9. doi: 10.1002/ana.22247. Epub 2010 Dec 8. Ann Neurol. 2011. PMID: 21280078
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
Jernås M, Malmeström C, Axelsson M, Olsson C, Nookaew I, Wadenvik H, Zetterberg H, Blennow K, Lycke J, Rudemo M, Olsson B. Jernås M, et al. Among authors: lycke j. Mult Scler. 2013 Apr;19(4):403-10. doi: 10.1177/1352458512455466. Epub 2012 Aug 20. Mult Scler. 2013. PMID: 22907940
Serum levels of LIGHT in MS.
Malmeström C, Gillett A, Jernås M, Khademi M, Axelsson M, Kockum I, Mattsson N, Zetterberg H, Blennow K, Alfredsson L, Wadenvik H, Lycke J, Olsson T, Olsson B. Malmeström C, et al. Among authors: lycke j. Mult Scler. 2013 Jun;19(7):871-6. doi: 10.1177/1352458512463766. Epub 2012 Oct 4. Mult Scler. 2013. PMID: 23037546
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N. Augutis K, et al. Among authors: lycke j. Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15. Mult Scler. 2013. PMID: 23069872
167 results